USA Africa Dialogue Series - Health innovation for the world's poor: Who are the players and what is the game?

A variety of public private partnering arrangements and innovative financing mechanisms has begun to change the neglected disease landscape over the last decade. How significant are these public-private partnership (PPP) arrangements? Are these players likely to endure? Do they deserve the continued support of development donors? How do they relate to broader shifts in the pharmaceutical industry?

http://www.genomicsnetwork.ac.uk/media/AGLS5%20-%20Health%20Innovation%20for%20the%20World%27s%20Poor.pdf 

--
You received this message because you are subscribed to the "USA-Africa Dialogue Series" moderated by Toyin Falola, University of Texas at Austin.
For current archives, visit http://groups.google.com/group/USAAfricaDialogue
For previous archives, visit http://www.utexas.edu/conferences/africa/ads/index.html
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To unsubscribe from this group, send an email to USAAfricaDialogue-
unsubscribe@googlegroups.com